Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · IEX Real-Time Price · USD
0.965
+0.046 (5.04%)
At close: Jul 2, 2024, 4:00 PM
0.940
-0.025 (-2.58%)
After-hours: Jul 2, 2024, 7:58 PM EDT
Hyperfine Market Cap
Hyperfine has a market cap or net worth of $69.48 million as of July 2, 2024. Its market cap has decreased by -55.97% in one year.
Market Cap
69.48M
Enterprise Value
6.28M
1-Year Change
-55.97%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since January 27, 2021, Hyperfine's market cap has decreased from $192.70M to $69.48M, a decrease of -63.94%. That is a compound annual growth rate of -25.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 66.20M | -17.46% |
| Dec 29, 2023 | 80.20M | 35.24% |
| Dec 30, 2022 | 59.30M | -90.62% |
| Dec 31, 2021 | 632.30M | 228.13% |
| Jan 27, 2021 | 192.70M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AN2 Therapeutics | 64.13M |
| Carisma Therapeutics | 63.14M |
| CEL-SCI | 62.83M |
| InspireMD | 62.28M |
| Cryo-Cell International | 61.68M |
| Personalis | 60.77M |
| Turnstone Biologics | 60.60M |
| Cue Biopharma | 60.32M |